Article info

Extended report
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
  1. Correspondence to Dr Pierre Quartier, Unite d'Immuno-Hematologie et Rhumatologie Pediatriques, Hopital Necker-Enfants Malades, 149 rue de Sevres 75 015 Paris, France; pierre.quartier{at}nck.aphp.fr
View Full Text

Citation

Quartier P, Allantaz F, Cimaz R, et al
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Publication history

  • Accepted November 11, 2010
  • First published December 20, 2010.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.